What is Zelboraf?
Zelboraf is a prescription oral chemotherapy drug designed for targeted cancer therapy. It is used to treat patients with specific types of melanoma, a serious form of skin cancer. This medication is specifically for cancers that have a particular genetic mutation known as BRAF V600E. Zelboraf is intended for cases where the melanoma cannot be surgically removed or has spread to other parts of the body (metastasized). It is also approved for treating Erdheim-Chester Disease with the same mutation. By focusing on cancer cells with this specific marker, it can be more effective than traditional chemotherapy for eligible patients.
How does Zelboraf work?
Zelboraf works by targeting a specific gene mutation called BRAF V600E. This gene can produce an altered protein that signals cancer cells to grow and divide uncontrollably. Zelboraf is a BRAF inhibitor. It blocks the action of this abnormal protein. This interruption of the faulty signal can slow down or even stop the proliferation of cancer cells. It selectively acts on the mutated cells. This makes it a form of personalized medicine. Its targeted action helps to spare healthy cells, which can lead to different side effects than traditional chemotherapy.
Who is Zelboraf for?
Zelboraf is for adult patients diagnosed with specific types of cancer characterized by the BRAF V600E mutation. Before starting treatment, your doctor must perform a test to confirm that your cancer has this specific genetic marker. It is primarily prescribed for unresectable or metastatic melanoma. Unresectable means the cancer cannot be removed with surgery. It is not indicated for use in patients who have wild-type BRAF melanoma. Additionally, Zelboraf is used to treat a rare blood disease called Erdheim-Chester Disease (ECD) that also has the BRAF V600E mutation.
Dosage and administration
Zelboraf is typically taken as an oral tablet, and you should always follow your doctor’s specific instructions for its use. The standard dose is usually 960 mg, taken twice daily. The tablets should be swallowed whole with a glass of water, about 12 hours apart. You can take Zelboraf with or without food. Do not crush or chew the tablets. If you miss a dose, you can take it up to 4 hours before the next scheduled dose. Do not take an extra dose to make up for a missed one. Consistency is key to maintaining the right level of medication in your body.
Side effects
Zelboraf may cause several side effects, which can range from mild to severe. The most common side effects include joint pain, rash, increased sun sensitivity, fatigue, hair loss, and nausea. It is very important to protect your skin from the sun while taking this medication. You should use sunscreen and wear protective clothing. More serious side effects can also occur. These may include severe skin reactions, heart rhythm problems (QT prolongation), liver damage, or eye issues. Contact your doctor immediately if you experience chest pain, severe skin blistering, or yellowing of the skin or eyes.
Why buy from IsraelPharm?
IsraelPharm provides a simple and secure way to access authentic medications like Zelboraf at competitive prices. We source our products only from legitimate manufacturers and authorized distributors. This ensures you receive high-quality, effective treatment. Our user-friendly online platform makes ordering your prescription easy. We offer discreet packaging and reliable shipping directly to your home. Our customer care team is available to assist with any questions. Choose IsraelPharm for a trustworthy and affordable way to manage your healthcare needs with confidence and convenience from a trusted online pharmacy.
Common Side Effects:
- Joint pain (arthralgia)
- Increased sensitivity to sunlight
- Rash
- Hair loss (alopecia)
- Fatigue
- Nausea
- Warts or other skin changes
Serious Side Effects (Contact your doctor immediately):
- Severe skin reactions (Stevens-Johnson syndrome)
- Development of new skin cancers (cutaneous squamous cell carcinoma)
- Heart rhythm problems (QT prolongation)
- Liver injury
- Eye problems like uveitis
- Kidney problems
Zelboraf (Vemurafenib) is a targeted therapy indicated for the treatment of:
- Patients with unresectable or metastatic melanoma whose tumors have a BRAF V600E mutation as detected by an approved test.
- Adult patients with Erdheim-Chester Disease (ECD) that has the BRAF V600E mutation.
It is not indicated for patients with wild-type BRAF melanoma.